FDA Inspection 1030229 — Chartwell Pharmaceuticals West Caldwell LLC
The FDA completed an inspection of Chartwell Pharmaceuticals West Caldwell LLC on Sep 18, 2017 in West Caldwell, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 18, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- West Caldwell, NJ (United States)